Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06193317 · ClinicalTrials.gov registry record · NA
Effects of taVNS on Fibromyalgia Pain
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Not yet
- Registry status
- NA
- Development phase
- 152
- Enrollment target
NCT06193317 is a NA study that has not yet begun recruiting, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 152 participants.
The verdict
NCT06193317, a NA study, has not yet begun recruiting, sponsored by Spaulding Rehabilitation Hospital.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
Study Summary
Transauricular vagus nerve stimulation (taVNS) is a newer delivery system, using a non-invasive stimulation device placed at the ear's concha. TaVNS is a portable, safe, and low-cost intervention, and according to some studies, taVNS may influence nociception and pain perception, which can lead to potential applications for various painful illnesses, including fibromyalgia (FM). This trial aims to investigate the clinical effects of taVNS on pain control in FM subjects.
Interventions
- DEVICE Transauricular vagus nerve stimulation (taVNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2029-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06193317
The ClinicalTrials.gov registry entry for NCT06193317 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transauricular vagus nerve stimulation (taVNS) is the first listed.
NCT06193317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06193317 about?
NCT06193317 is a clinical study titled "Effects of taVNS on Fibromyalgia Pain". Transauricular vagus nerve stimulation (taVNS) is a newer delivery system, using a non-invasive stimulation device placed at the ear's concha. TaVNS is a portable, safe, and low-cost intervention, and according to some studies, taVNS may influence nociception and pain perception, which can lead to p...
What is the current status of trial NCT06193317?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2026-06-01. Estimated completion is 2029-05-01.
What interventions are being tested in trial NCT06193317?
The interventions under investigation include: Transauricular vagus nerve stimulation (taVNS) (DEVICE).
Who is sponsoring clinical trial NCT06193317?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.